Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grey

Showing results (291-300 of 314) with videos related to

Pageof 32
Sort By:
Cell|July 1, 1994
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor bindingR C Robinson, L M Grey, D Staunton, et al.
Vaccine|June 17, 1998
Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responsesC Oseroff, A Sette, P Wentworth, et al.
Current Genetics|April 4, 1998
Low glutathione pools in the original pso3 mutant of Saccharomyces cerevisiae are responsible for its pleiotropic sensitivity phenotypeM Brendel, M Grey, A F Maris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactionsA Sette, J Sidney, C Oseroff, et al.
Journal of Cell Science|October 1, 1996
Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectinS L Schor, I Ellis, C Dolman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptidesM E Ressing, A Sette, R M Brandt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognitionJ I Krieger, R W Karr, H M Grey, et al.
Immunogenetics|January 1, 1997
Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modesA Kondo, J Sidney, S Southwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I moleculesA Kondo, J Sidney, S Southwood, et al.
Clinical Radiology|January 20, 2021
Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR)F Moloney, R G Kavanagh, N J Ronan, et al.
Pageof 32

Showing results (291-300 of 314) with videos related to

Sort By:
Pageof 32
Cell|July 1, 1994
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor bindingR C Robinson, L M Grey, D Staunton, et al.
Vaccine|June 17, 1998
Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responsesC Oseroff, A Sette, P Wentworth, et al.
Current Genetics|April 4, 1998
Low glutathione pools in the original pso3 mutant of Saccharomyces cerevisiae are responsible for its pleiotropic sensitivity phenotypeM Brendel, M Grey, A F Maris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactionsA Sette, J Sidney, C Oseroff, et al.
Journal of Cell Science|October 1, 1996
Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectinS L Schor, I Ellis, C Dolman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptidesM E Ressing, A Sette, R M Brandt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1991
Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognitionJ I Krieger, R W Karr, H M Grey, et al.
Immunogenetics|January 1, 1997
Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modesA Kondo, J Sidney, S Southwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I moleculesA Kondo, J Sidney, S Southwood, et al.
Clinical Radiology|January 20, 2021
Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR)F Moloney, R G Kavanagh, N J Ronan, et al.
Pageof 32